| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $41,989,780 ) (Continued on the next page) |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | T2331579 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $904,460 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | T2331579 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $2,645,770 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | T2331579 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $1,753,396 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | T2331579 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $5,129,116 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL162715 | Impact of Obesity on Lung Macrophage Metabolism and Inflammation | 001 | 4 | NIH | 3/25/2026 | $17,342 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL162715 | Impact of Obesity on Lung Macrophage Metabolism and Inflammation | 000 | 4 | NIH | 2/9/2026 | $549,173 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK141778 | Urinary peptidomics for neurogenic bladder risk stratification in patients with spina bifida | 000 | 1 | NIH | 2/6/2026 | $796,742 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK141691 | Mechanistic human studies to prevent Hirschsprung-associated enterocolitis | 000 | 2 | NIH | 12/4/2025 | $696,732 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DE033646 | Mechanisms of Macroglossia in Beckwith-Wiedemann Syndrome | 000 | 2 | NIH | 1/27/2026 | $702,545 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK054937 | Transcriptional Networks Controlling Erythroid Differentiation | 000 | 27 | NIH | 3/23/2026 | $752,242 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK112955 | Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1 | 000 | 9 | NIH | 12/3/2025 | $710,595 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DE032332 | Functional analysis of ESRP1/2 and CTNND1 gene variants in orofacial cleft | 000 | 4 | NIH | 1/14/2026 | $551,976 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK118155 | Intersection of signaling pathways and transcription factors regulating islet development | 000 | 8 | NIH | 12/23/2025 | $803,496 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK135871 | Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood | 000 | 4 | NIH | 3/5/2026 | $563,633 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK134717 | Vitamin D control of calorie allocation to muscle | 000 | 4 | NIH | 1/5/2026 | $509,945 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK133453 | Leveraging early-life microbes to prevent type 1 diabetes | 000 | 4 | NIH | 3/5/2026 | $721,401 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA258524 | Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis | 000 | 6 | NIH | 1/16/2026 | $754,071 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA271523 | Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies | 000 | 5 | NIH | 3/4/2026 | $547,313 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA269788 | IDP mediated transcriptional stabilization as a cause of AML | 000 | 5 | NIH | 3/25/2026 | $240,090 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI184976 | Genetic determinates of SPI1 expression and activity in human germinal center B cells | 000 | 2 | NIH | 1/26/2026 | $801,574 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI187335 | Manipulation of the DNA damage response and the proteome on viral genomes during Herpes Simplex Virus (HSV) infection | 000 | 2 | NIH | 12/1/2025 | $671,993 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI195638 | Role of the PilC1 and PilC2 pilus-associated proteins in Kingella kingae pathogenicity | 001 | 1 | NIH | 2/26/2026 | $19,500 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI195638 | Role of the PilC1 and PilC2 pilus-associated proteins in Kingella kingae pathogenicity | 000 | 1 | NIH | 2/17/2026 | $833,612 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI187222 | Cul5 dampens cytokine sensing in Type II lymphocytes to prevent allergic airways remodeling | 000 | 1 | NIH | 2/4/2026 | $670,017 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI187202 | Chronic STAT3 signaling in STAT3 GOF causes CD8 T cell dysfunction via CD39 upregulation | 000 | 2 | NIH | 12/31/2025 | $709,449 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI189552 | Adenovirus regulation of cellular RNA binding proteins | 000 | 2 | NIH | 12/30/2025 | $751,552 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA193776 | Improving risk allocation and developing novel therapies for children with T-ALL and T-LL | 000 | 9 | NIH | 1/27/2026 | $663,617 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR083903 | Regulation of Skeletal Growth and Regeneration | 001 | 2 | NIH | 1/29/2026 | $340,425 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AR083245 | FGFR3 Activities in the Control of Skeletal Growth | 000 | 3 | NIH | 3/26/2026 | $630,824 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI172841 | Pathogenicity of the emerging pathogen Kingella kingae | 000 | 4 | NIH | 11/28/2025 | $445,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI182049 | The B22 family of orthopoxvirus virulence factors: Investigating structure/function of these potent, multifaceted immunoevasins | 000 | 3 | NIH | 1/1/2026 | $742,230 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI181999 | Cul5 regulates lung ILC2 cells during helminth infection | 000 | 2 | NIH | 12/1/2025 | $674,760 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI179680 | The molecular circuits controlling human T follicular regulatory cell development | 000 | 2 | NIH | 1/7/2026 | $854,971 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AG077911 | Illuminating adipo-osteoprogenitors in the bone marrow | 000 | 4 | NIH | 1/16/2026 | $415,678 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AG077911 | Illuminating adipo-osteoprogenitors in the bone marrow | 001 | 4 | NIH | 2/24/2026 | $46,186 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R00HL177830 | NET stabilization: mechanistic and therapeutic studies studying the role of NETs in thromboinflammatory disease | 000 | 2 | NIH | 2/27/2026 | $445,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R00AI163348 | Operationalizing wastewater-based surveillance of multidrug-resistant bacteria | 000 | 4 | NIH | 1/22/2026 | $91,675 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K24AI185302 | Advancing Mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria | 001 | 2 | NIH | 1/15/2026 | $204,153 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R37AI067946 | Directing Function at the Natural Killer Cell Secretory Immunological Synapse | 001 | 17 | NIH | 12/30/2025 | $546,512 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R37CA282041 | GPC2 CARs in neuroblastoma: Mechanisms of resistance and efficacy of next-generation constructs | 000 | 3 | NIH | 3/20/2026 | $585,133 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R35GM138369 | Defining principles shaping microbial niches in the early life gut | 000 | 6 | NIH | 2/16/2026 | $489,500 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21DA065088 | Antioxidant and blood flow profiling in individuals with HIV | 001 | 1 | NIH | 3/11/2026 | $0 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21DA065088 | Antioxidant and blood flow profiling in individuals with HIV | 000 | 1 | NIH | 2/20/2026 | $456,268 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21AI182619 | Potent Signal 1 as a noncanonical Signal 3: antigen location, and peptide:MHCII complex density and half-life as drivers of CD4+ T cell differentiation | 000 | 2 | NIH | 12/10/2025 | $222,500 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R03CA293992 | Long-read, single-cell RNA sequencing of high-risk neuroblastoma samples | 000 | 2 | NIH | 12/23/2025 | $160,200 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS110869 | Interneuron axonopathy underlies circuit dysfunction in a mouse model of Dravet syndrome | 000 | 7 | NIH | 2/24/2026 | $674,970 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS120099 | INJURY-INDUCED SPATIAL MEMORY IMPAIRMENTS ARE LINKED TO UNCOORDINATED HIPPOCAMPAL NEURONAL FIRING | 001 | 5 | NIH | 2/28/2026 | $44,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS120099 | INJURY-INDUCED SPATIAL MEMORY IMPAIRMENTS ARE LINKED TO UNCOORDINATED HIPPOCAMPAL NEURONAL FIRING | 000 | 5 | NIH | 12/16/2025 | $396,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS137604 | A developmental mechanism of temperature-sensitive seizures towards therapeutic manipulation | 000 | 2 | NIH | 1/31/2026 | $517,460 |
|
